Motor fluctuations in Parkinson's disease

Journal of the Neurological Sciences

Volumn 165, Issue 1, 1999, Pages 18-23

  Denny, Anto P ^a   Behari, Madhuri ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Complications; Dyskinesia; Dystonia; Levodopa; Motor blocks

Indexed keywords

LEVODOPA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSKINESIA; DYSTONIA; FEMALE; HUMAN; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DISEASE PROGRESSION; DYSTONIA; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOVEMENT; MOVEMENT DISORDERS; PARKINSON DISEASE; RISK FACTORS;

EID: 0033136414     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00052-0     Document Type: Article

References (19)

1. Marsden C.D., Parkes J.D. Success and problems of long term levodopa therapy in Parkinson's disease. Lancet. 1:1977;345-349.
2. Fabbrini G., Mouradian M.M., Juncos J.L., Schegel J., Mohr E., Chase T.N. Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms. Part I. Ann Neurol. 24:1988;366-371.
3. Barbeau A. Six years of high-level levodopa therapy in severely akinetic parkinsonian patients. Arch Neurol. 33:1976;333-338.
4. Lesser R.P., Fahn S., Snider S.R., Cote L.G., Isgreen W.P., Barrett R.E. Analysis of clinical problems in parkinsonism and the complications of long term levodopa therapy. Neurology. 29:1979;1253-1260.
5. Rajput A.H., Stern W., Laverty W.H. Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy. Neurology. 34:1984;991-996.
6. Markham C.H., Diamond S.G. Evidence to support early levodopa therapy in Parkinson's disease. Neurology. 31:1981;125-131.
7. Cedarbaum J.M., Gandy S.E., Mcdowell F.H. Early initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias or dementia in Parkinson's disease. Neurology. 41:1991;622-629.
8. DeJong G.J., Meervaldt J.D., Schimtz P.I.M. Factors that influence the occurrence of response variations in Parkinson's disease. Ann Neurol. 22:1987;4-7.
9. Caraceni T., Scigliano G., Mussico M. The occurrence of motor fluctuations in parkinsonian patients treated long term with levodopa. Neurology. 41:1991;380-384.
10. Kostic V., Prazedborski S., Flaster E., Sternic N. Early development of levodopa induced dyskinesias and response fluctuations in young onset Parkinson's disease. Neurology. 41:1991;202-205.
11. Gibbs W.R.G., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 51:1988;745-752.
12. Giladi N., McMohan D., Przedboriski S., Flaster E., Guillory S., Kostic S., Fahn S. Motor blocks in Parkinson's disease. Neurology. 42:1992;333-339.
13. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology. 7:1967;427-442.
14. Fahn S., Elton R.L. Unified Parkinson's disease rating scale. Fahn S., Marsden C.D., Goldstein M., Calne D.B. Recent developments in Parkinson's disease 2. 1987;153-163 Macmillan, New York. Appendices I, II.
15. Schwab K.S. Progression and prognosis in Parkinson's disease. J Nerv Ment Dis. 130:1960;556-566.
16. Markham C.H., Diamond S.G. Long term follow-up of early dopa treatment in Parkinson's disease. Ann Neurol. 19:1986;365-372.
17. Horstink M.W.I.M., Ziglmans J.C.M., Pasman J.W., Berger H.J.C., Korten J.J., Van't Hof M.A. Which risk factors predict the levodopa response in fluctuating Parkinson's disease? Ann Neurol. 27:1990;534-537.
18. Melamed E. Early morning dystonia; a late side effect of long term levodopa therapy in Parkinson's disease. Arch Neurol. 6:1979;308-310.
19. Schwab R.S., England A.C., Peterson E. Akinesia in Parkinsons disease. Neurology. 9:1959;65-72.